Aiping H. Young

Person

North York, CA

People

Patents Grantslast 30 patents

Information Patent Grant
Aryl imidazoles and their use as anti-cancer agents
- Patent number 10,080,739
- Issue date Sep 25, 2018
- Aptose Biosciences Inc.
- Mario Huesca
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2-substituted imidazo[4,5-D]phenanthroline derivatives and their us...
- Patent number 9,309,247
- Issue date Apr 12, 2016
- LORUS THERAPEUTICS INC.
- Yoon Lee
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
- Patent number 8,987,305
- Issue date Mar 24, 2015
- Aptose Biosciences Inc.
- Raed H. Al-Qawasmeh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Aryl imidazoles and their use as anti-cancer agents
- Patent number 8,969,372
- Issue date Mar 3, 2015
- Aptose Boisciences Inc.
- Mario Huesca
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
- Patent number 8,394,815
- Issue date Mar 12, 2013
- Lorus Therapeutics Inc.
- Raed H. Al-Qawasmeh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination preparation of a biological response modifier and an an...
- Patent number 8,394,418
- Issue date Mar 12, 2013
- Erin Mills Biotech Inc.
- Aiping Young
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of interleukin 17E for the treatment of cancer
- Patent number 8,287,851
- Issue date Oct 16, 2012
- Lorus Therapeutics Inc.
- Jim A. Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2-indolyl imidazo [4,5-d] phenanthroline derivatives and their use...
- Patent number 8,148,392
- Issue date Apr 3, 2012
- Lorus Therapeutics Inc.
- Mario Huesca
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antisense oligonucleotides directed to ribonucleotide reductase R2...
- Patent number 7,968,526
- Issue date Jun 28, 2011
- Lorus Therapeutics Inc.
- Jim A. Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
- Patent number 7,884,120
- Issue date Feb 8, 2011
- Lorus Therapeutics Inc.
- Raed Al-Qawasmeh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antitumor antisense sequences directed against R1 and R2 components...
- Patent number 7,405,205
- Issue date Jul 29, 2008
- Lorus Therapeutics Inc.
- Jim A. Wright
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Oligonucleotides from the untranslated regions of housekeeping gene...
- Patent number 7,223,849
- Issue date May 29, 2007
- Genesense Technologies Inc.
- Jim A. Wright
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Neuropilin antisense oligonucleotide sequences and methods of using...
- Patent number 7,087,580
- Issue date Aug 8, 2006
- Genesense Technologies, Inc.
- Jim A. Wright
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antisense oligonucleotide sequences as inhibitors of microorganisms
- Patent number 6,610,539
- Issue date Aug 26, 2003
- Genesense Technologies, Inc.
- Jim A. Wright
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Oligonucleotide sequences complementary to thioredoxin or thioredox...
- Patent number 6,566,514
- Issue date May 20, 2003
- Genesense Technologies Inc.
- Jim A. Wright
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Suppression of malignancy utilizing ribonucleotide reductase R1
- Patent number 6,472,376
- Issue date Oct 29, 2002
- Genesense Technologies, Inc.
- Jim A. Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Insulin-like growth factor II antisense oligonucleotide sequences a...
- Patent number 6,417,169
- Issue date Jul 9, 2002
- Genesense Technologies Inc.
- Jim A. Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antitumor antisense sequences directed against R1 and R2 components...
- Patent number 6,121,000
- Issue date Sep 19, 2000
- Genesense Technologies, Inc.
- Jim A. Wright
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antitumor antisense sequences directed against ribonucleotide reduc...
- Patent number 5,998,383
- Issue date Dec 7, 1999
- Jim A. Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
2-SUBSTITUTED IMIDAZO[4,5-D]PHENANTHROLINE DERIVATIVES AND THEIR US...
- Publication number 20160176876
- Publication date Jun 23, 2016
- Aptose Biosciences Inc.
- Yoon LEE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2-SUBSTITUTED IMIDAZO[4,5-D]PHENANTHROLINE DERIVATIVES AND THEIR US...
- Publication number 20160031883
- Publication date Feb 4, 2016
- Aptose Biosciences Inc.
- Yoon LEE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ARYL IMIDAZOLES AND THEIR USE AS ANTI-CANCER AGENTS
- Publication number 20150374669
- Publication date Dec 31, 2015
- Aptose Biosciences Inc.
- Mario HUESCA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2,4,5-TRISUBSTITUTED IMIDAZOLES AND THEIR USE AS ANTI-MICROBIAL AGENTS
- Publication number 20130177632
- Publication date Jul 11, 2013
- Raed H. Al-Qawasmeh
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
USE OF INTERLEUKIN 17E FOR THE TREATMENT OF CANCER
- Publication number 20110158936
- Publication date Jun 30, 2011
- Lorus Therapeutics Inc.
- Jim A. Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2,4,5-TRISUBSTITUTED IMIDAZOLES AND THEIR USE AS ANTI-MICROBIAL AGENTS
- Publication number 20110152337
- Publication date Jun 23, 2011
- Lorus Therapeutics Inc.
- RAED H. AL-QAWASMEH
- A23 - FOODS OR FOODSTUFFS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
Information Patent Application
COMBINATION PREPARATION OF A BIOLOGICAL RESPONSE MODIFIER AND AN AN...
- Publication number 20110111047
- Publication date May 12, 2011
- Aiping H. Young
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SMALL INTERFERING RNA MOLECULES AGAINST RIBONUCLEOTIDE REDUCTASE AN...
- Publication number 20100204305
- Publication date Aug 12, 2010
- Lorus Therapeutics Inc.
- Aiping H. YOUNG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antisense Oligonucleotides Directed to Ribonucleotide Reductase R2...
- Publication number 20100197766
- Publication date Aug 5, 2010
- Lorus Therapeutics Inc.
- Jim A. WRIGHT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2-Indolyl Imidazo [4,5-d] Phenanthroline Derivatives and Their Use...
- Publication number 20100168417
- Publication date Jul 1, 2010
- Mario Huesca
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Antisense Oligonucleotides Directed to Ribonucleotide Reductase R2...
- Publication number 20090118205
- Publication date May 7, 2009
- Lorus Therapeutics Inc.
- Jim WRIGHT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antisense Oligonucleotides Directed to Ribonucleotide Reducatase R2...
- Publication number 20080311126
- Publication date Dec 18, 2008
- Genesense Technologies, Inc
- Aiping H. Young
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination Preparation of a Biological Response Modifier and an An...
- Publication number 20080279818
- Publication date Nov 13, 2008
- Aiping H. Young
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Aryl imidazoles and their use as anti-cancer agents
- Publication number 20080262015
- Publication date Oct 23, 2008
- LORUS THERAPEUTICS INC.
- Mario Huesca
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Small Interfering Rna Molecules Against Ribonucleotide Reductase an...
- Publication number 20080255065
- Publication date Oct 16, 2008
- GENESENSE TECHNOLOGIES, INC.
- Aiping H. Young
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Antisense Oligonucleotides Directed to Ribonucleotide Reductase R1...
- Publication number 20070274947
- Publication date Nov 29, 2007
- Aiping H. Young
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Aryl imidazoles and their use as anti-cancer agents
- Publication number 20070123553
- Publication date May 31, 2007
- LORUS THERAPEUTICS INC.
- Mario Huesca
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Vector utilizing ribonuclease reductase UTR and use for inhibiting...
- Publication number 20070032442
- Publication date Feb 8, 2007
- GENESENSE TECHNOLOGIES INC.
- Jim A. Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination preparation of a biological response modifier and an an...
- Publication number 20060034938
- Publication date Feb 16, 2006
- Aiping H. Young
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Biological response modifier for the treatment of cancer
- Publication number 20050192443
- Publication date Sep 1, 2005
- Lorus Therapeutics Inc.
- Aiping H. Young
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Biological response modifier composition and uses thereof
- Publication number 20040198819
- Publication date Oct 7, 2004
- Aiping H. Young
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination preparation of a biological response modifier and an an...
- Publication number 20040101511
- Publication date May 27, 2004
- Aiping H Young
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antitumor antisense sequences directed against R1 and R2 components...
- Publication number 20040009948
- Publication date Jan 15, 2004
- GENESENSE TECHNOLOGIES INC.
- Jim A. Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Suppression of malignancy utilizing ribonucleotide reductase R1
- Publication number 20030087866
- Publication date May 8, 2003
- GENESENSE TECHNOLOGIES INC.
- Jim A. Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEUROPILIN ANTISENSE OLIGONUCLEOTIDE SEQUENCES AND METHODS OF USING...
- Publication number 20030083274
- Publication date May 1, 2003
- JIM A. WRIGHT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Insulin-like growth factor II antisense oligonucleotide sequences a...
- Publication number 20020187954
- Publication date Dec 12, 2002
- GENESENSE TECHNOLOGIES INC.
- Jim A. Wright
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SUPRESSION OF MALIGNANCY UTILIZING RIBONUCLEOTIDE REDUCTASE R1
- Publication number 20020004488
- Publication date Jan 10, 2002
- JIM A. WRIGHT
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Aiping H. Young

Person

Patents Grantslast 30 patents

Aryl imidazoles and their use as anti-cancer agents

2-substituted imidazo[4,5-D]phenanthroline derivatives and their us...

2,4,5-trisubstituted imidazoles and their use as anti-microbial agents

Aryl imidazoles and their use as anti-cancer agents

2,4,5-trisubstituted imidazoles and their use as anti-microbial agents

Combination preparation of a biological response modifier and an an...

Use of interleukin 17E for the treatment of cancer

2-indolyl imidazo [4,5-d] phenanthroline derivatives and their use...

Antisense oligonucleotides directed to ribonucleotide reductase R2...

2,4,5-trisubstituted imidazoles and their use as anti-microbial agents

Antitumor antisense sequences directed against R1 and R2 components...

Oligonucleotides from the untranslated regions of housekeeping gene...

Neuropilin antisense oligonucleotide sequences and methods of using...

Antisense oligonucleotide sequences as inhibitors of microorganisms

Oligonucleotide sequences complementary to thioredoxin or thioredox...

Suppression of malignancy utilizing ribonucleotide reductase R1

Insulin-like growth factor II antisense oligonucleotide sequences a...

Antitumor antisense sequences directed against R1 and R2 components...

Antitumor antisense sequences directed against ribonucleotide reduc...

Patents Applicationslast 30 patents

2-SUBSTITUTED IMIDAZO[4,5-D]PHENANTHROLINE DERIVATIVES AND THEIR US...

2-SUBSTITUTED IMIDAZO[4,5-D]PHENANTHROLINE DERIVATIVES AND THEIR US...

ARYL IMIDAZOLES AND THEIR USE AS ANTI-CANCER AGENTS

2,4,5-TRISUBSTITUTED IMIDAZOLES AND THEIR USE AS ANTI-MICROBIAL AGENTS

USE OF INTERLEUKIN 17E FOR THE TREATMENT OF CANCER

2,4,5-TRISUBSTITUTED IMIDAZOLES AND THEIR USE AS ANTI-MICROBIAL AGENTS

COMBINATION PREPARATION OF A BIOLOGICAL RESPONSE MODIFIER AND AN AN...

SMALL INTERFERING RNA MOLECULES AGAINST RIBONUCLEOTIDE REDUCTASE AN...

Antisense Oligonucleotides Directed to Ribonucleotide Reductase R2...

2-Indolyl Imidazo [4,5-d] Phenanthroline Derivatives and Their Use...

Antisense Oligonucleotides Directed to Ribonucleotide Reductase R2...

Antisense Oligonucleotides Directed to Ribonucleotide Reducatase R2...

Combination Preparation of a Biological Response Modifier and an An...

Aryl imidazoles and their use as anti-cancer agents

Small Interfering Rna Molecules Against Ribonucleotide Reductase an...

Antisense Oligonucleotides Directed to Ribonucleotide Reductase R1...

Aryl imidazoles and their use as anti-cancer agents

Vector utilizing ribonuclease reductase UTR and use for inhibiting...

Combination preparation of a biological response modifier and an an...

Biological response modifier for the treatment of cancer

Biological response modifier composition and uses thereof

Combination preparation of a biological response modifier and an an...

Antitumor antisense sequences directed against R1 and R2 components...

Suppression of malignancy utilizing ribonucleotide reductase R1

NEUROPILIN ANTISENSE OLIGONUCLEOTIDE SEQUENCES AND METHODS OF USING...

Insulin-like growth factor II antisense oligonucleotide sequences a...

SUPRESSION OF MALIGNANCY UTILIZING RIBONUCLEOTIDE REDUCTASE R1